Latest Breaking News On - Quarterly reports on firm - Page 1 : comparemela.com

NEW YORK, April 05, 2023 Y-mAbs Therapeutics, Inc. a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products. | April 5, 2023

New yorkUnited statesMemorial sloan kettering cancer centerNai kong cheungGlobenewswire incQuarterly reports on firmMassachusetts institute of technologyY mabs therapeutics incAbs therapeuticsSloan kettering cancer centerKong cheungPrivate securities litigation reform actAnnual reportQuarterly reportsY mabs therapeuticsNc stock exchange